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ABSTRACT 
Objective: To assess the spectrum and prevalence of mutations in the GJB2 gene in Portuguese 
nonsyndromic sensorineural hearing loss (NSSHL) patients. Design: Sequencing of the coding region, 
basal promoter, exon 1 and donor splice site of the GJB2 gene; screening for the presence of the two 
common GJB6 deletions. Study sample: A cohort of 264 Portuguese NSSHL patients. Results: At least 
one out of 21 different GJB2 variants was identified in 80 (30.2%) of the 264 patients analysed. Two 
mutant alleles were found in 53 (20%) of these probands, of which 83% (44/53) harboured at least 
one c.35delG allele. Twenty-seven (10.2%) of the probands harboured only one mutant allele. 
Subsequent analysis revealed that the GJB6 deletion del(GJB6-D13S1854) was present in at least 
7.4% (2/27) of the patients carrying only one mutant GJB2 allele. Overall, one in five (55/264) of the 
patients were diagnosed as having DFNB1-related NSSHL, of which the vast majority (53/55) 
harboured only GJB2 mutations. Conclusions: This study provides clear demonstration that 
mutations in the GJB2 gene are an important cause of NSSHL in Portugal, thus representing a 
valuable indicator as regards therapeutical and rehabilitation options, as well as genetic counseling 
of these patients and their families. 
 
INTRODUCTION 
Hearing loss (HL) is the most common congenital sensory impairment, and the most prevalent 
sensorineural disorder (Hilgert, Smith et al, 2009), being a major public health concern. 
 
Regarding nonsyndromic sensorineural hearing loss (NSSHL), more than 140 genetic loci have been 
mapped, with more than 60 genes identified to date (Alford, 2011; Smith & Van Camp, 2011). 
Despite this extreme genetic heterogeneity, mutations in the GJB2 gene, encoding the protein 
connexin 26 (Cx26), are a major cause of NSSHL in many world populations, which makes GJB2 the 
gene most frequently associated with this condition. Two gross deletions, del(GJB6-D13S1830) and 
del(GJB6-D13S1854), involving the GJB6 gene, which codes for connexin 30 (Cx30), have also been 
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Matos GJB2 mutations and NSSHL in Portugal 3 
associated with nonsyndromic hearing loss (NSHL) in several cases, often in trans with a GJB2 
mutation (del Castillo FJ et al, 2005; Lerer et al, 2001; Pallares et al, 2002). Both genes, GJB2 and 
GJB6, are localised to chromosome region 13q11, corresponding to the DFNB1 locus. 
 
About two hundred GJB2 mutations causing nonsyndromic HL have been reported (Stenson et al, 
2009), most of them being recessive. A few specific mutations in GJB2 also have been described in 
families with autosomal dominant HL (Smith, Sheffield et al, 2012). The carrier rate in the general 
population for a recessive deafness-causing GJB2 mutation is approximately one in 33 (Smith, 
Shearer et al, 2013). 
 
The spectrum and the prevalence of GJB2 mutations vary among different populations. The 
predominant mutations in Europeans, Ashkenazi Jews, East Asians, and Ghanese population are 
c.35delG, c.167delT, c.235delC and p.R143W, respectively (Kenneson et al, 2002). A different GJB2 
pathogenic mutation, p.W24X, was found to be the predominant one in NSHL cases in India 
(RamShankar et al, 2003), and in Gypsies (an ethnic group that traces back to the Indian 
subcontinent) from Eastern Slovakia (Minárik et al, 2003) and Spain (Álvarez et al, 2005). This 
mutation was also shown to have a high carrier frequency (2.4%) in the Indian population 
(RamShankar et al, 2003), and in some subpopulations of Gypsies (Minárik et al, 2003; Álvarez et al, 
2005]. 
 
Due to the high frequency of GJB2 mutations among NSHL cases in several populations worldwide, 
mutation analysis of this gene is a widely available genetic test, representing the first step in the 
molecular diagnosis of this pathology. 
 
Since most GJB2 mutations described so far localize to the coding region (totally included within exon 
2), only this region has been systematically analysed. Nonetheless, a few noncoding pathogenic 
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mutations have already been identified, contributing to the elucidation of the genetic etiology of the 
HL in some patients who harboured only one recessive mutation in the GJB2 coding region 
(Denoyelle et al, 1999; Mani et al, 2009; Matos et al, 2007). 
 
We here present a comprehensive molecular analysis of the GJB2 gene in a cohort of 264 Portuguese 
NSSHL patients. 
 
MATERIALS AND METHODS 
Patients 
A total of 264 Portuguese unr lated individuals (sporadic and familial cases), presenting with bilateral 
mild to profound NSSHL were tested for the presence of mutations in the DFNB1 locus. They had 
been referred over the last ten years, from various otolaryngology departments and genetic units, 
and come from different regions of the country. A recessive mode of inheritance was predominantly 
observed in the familial cases. 
 
Diagnosis of NSSHL was established by accepted clinical criteria. Infection, oto-trauma or neonatal 
diseases causing acquired deafness were excluded by collecting detailed clinical history. Individuals 
referred as not having been born in Portugal were also not considered. 
 
Written informed consent was obtained from all the participants or from parents in case of those 
younger than 18 years. 
 
Audiological methods 
All patients involved in the study underwent otoscopic and audiometric examinations by using age-
appropriate methods. Pure tone audiometry, tympanometry and auditory brainstem response were 
obtained in a sound proof room according to current clinical standards. We were not able to retrieve 
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Matos GJB2 mutations and NSSHL in Portugal 5 
medical history and audiometric records for all the patients. For some patients family histories were 
unknown. 
 
Molecular analysis 
Blood samples were obtained from most subjects.  DNA extraction from whole blood has been 
performed since the beginning of the study using either Quiagen or JetQuick DNA extraction kits. For 
some patients DNA was extracted from buccal swabs using the Chelex method. 
 
All DNA samples were first screened for the c.35delG mutation by PCR-mediated site-directed 
mutagenesis (PSDM) followed by restriction fragment length polymorphism (RFLP) analysis (Storm et al, 
1999). 
 
The c.35delG homozygotes were diagnosed as having GJB2-related HL and, consequently, no other 
studies were performed. 
 
Initially, the c.35delG heterozygotes and the negative cases had been screened by single-strand 
conformational polymorphism (SSCP) analysis, according to Scott et al (1998), followed by 
sequencing of the relevant GJB2 fragment.  In more recent years, all new cases falling into the two 
above mentioned situations have instead been analysed by direct sequencing of the entire coding 
region and flanking acceptor splice site, as previously described (Matos et al, 2010). Those c.35delG 
heterozygotes first analysed by SSCP and in which no second variant had been identified, as well 29 
of the 105 c.35delG negative cases which revealed no changes in the subsequent SSCP analysis, were 
further sequenced for the entire coding region and flanking acceptor splice site.  
 
If the cause of deafness remained non-elucidated, the patients were then screened for the del(GJB6-
D13S1830) and del(GJB6-D13S1854) GJB6 deletions using multiplex PCR, as described in the 
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literature (del Castillo F J et al, 2005). Twelve cases could not be analysed for any of the GJB6 
deletions (eight cases negative for GJB2 mutations plus four c.35delG heterozygotes), and two cases 
(both negative for GJB2 mutations) could only be screened for del(GJB6-D13S1830), since the 
corresponding DNAs had meanwhile run out, or had degraded, especially those DNAs extracted from 
buccal swabs. 
Ninety patients among those found not to harbour any GJB6 deletion have been screened by 
sequencing for mutations in the GJB2 basal promoter, exon 1 and donor splice site. Results 
concerning eighty-three of these 90 patients have been reported (Matos et al, 2008, 2007, 2011, 
2010). 
 
RESULTS 
At least one out of 21 different GJB2 variants (18 coding and three noncoding) was found in 80 
(30.2%) of the 264 patients representing a total of 133/528 (25%) mutated alleles (see Table 1). All 
the variants here identified were previously described, with the exception of the novel variant 
c.24G>A, which results in a silent mutation at protein level (p.T8T). Two of the reported mutations 
(c.-259C>T and p.M163L), listed in Table 1, were first identified in Portuguese patients (Matos et al, 
2008, 2007) included in the sample under analysis. As expected, c.35delG was the mutation most 
frequently found amongst the NSSHL patients, being present in 84 of the 528 chromosomes 
analysed, which corresponds to a prevalence of 15.9% (see Table 1) and a frequency of 63% of all 
mutated alleles. 
 
Table 2 shows the frequencies of GJB2 genotypes identified in a total of 264 individuals presenting 
with bilateral NSSHL. Fifty-three probands (20%) harboured two GJB2 mutations, of which 83% 
(44/53) harboured at least one c.35delG allele. The most prevalent mutated genotype was 
[c.35delG]+[c.35delG], accounting for 52.8% (28/53) of the individuals with two GJB2 mutations. Next 
to this genotype, [c.35delG]+[p.E47X)], [c.35delG]+[p. W172X)] and [c.35delG]+[p.V37I] genotypes 
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Matos GJB2 mutations and NSSHL in Portugal 7 
were the most represented among patients with two GJB2 mutations (respectively 5.7%,  5.7%, and 
3.8%). 
 
Twenty-seven out of 264 (10.2%) probands harboured only one GJB2 variant. Subsequent analysis 
revealed that the GJB6 deletion del(GJB6-D13S1854) was present in two of those patients (one 
heterozygous for c.35delG plus one heterozygous for p.M34T), both with prelingual, profound HL. 
One other patient solely harboured the dominant p.M163L mutation which has been previously 
described (Matos et al, 2008). 
 
DISCUSSION 
A wide spectrum of GJB2 variants, mostly pathogenic, was observed in the cohort of 264 NSSHL 
Portuguese individuals included in this study. Some variants of unclear effect (insufficient published 
data to infer pathogenicity) or of controversial pathogenicity (contradictory published data regarding 
pathogenicity) were also identified. 
 
The DFNB1 genotype explained the HL, or was a likely cause of the pathology, in 20.8% (55/264) of 
the cases. All but two of these cases (53/55), corresponding to 20.8% of all the patients analysed, 
were presumed to be due to the GJB2 genotype and thus considered as GJB2-related HL. For the 
remaining two patients (2/55) the HL could be explained by the presence of a coding GJB2 mutation 
(c.35delG or c.Met34Thr) and the GJB6 del(GJB6-D13S1854), both in heterozygosity. The GJB2-
related cases also include the patient harbouring the above referred dominant p.M163L mutation 
(Matos et al, 2008). Noteworthy, the HL in three patients with one coding GJB2 mutation was 
explained by the presence of a second GJB2 mutation in the basal promoter (c.-259C>T) or in the 
donor splice site (c.-23+1G>A). To our knowledge, the c.-259C>T mutation is so far restricted to the 
Portuguese family here presented. This mutation was not found in 91 normal-hearing Portuguese 
individuals from the general population (Matos et al, 2011) and reporter gene assays have shown 
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Matos GJB2 mutations and NSSHL in Portugal 8 
that the mutation greatly impairs the promoter function (Matos et al, 2007).The finding of GJB2 
pathogenic mutations in the basal promoter and donor splice site highlights the relevance of 
screening those noncoding regions in addition to the coding region.  
 
The deletion c.35delG was the predominant GJB2 mutation among GJB2-related HL cases, in 
accordance with other European or of mainly European descent populations (Dalámon et al, 2010; 
Pandya et al, 2003; Roux et al, 2004). Individuals homozygous for the c.35delG mutation accounted 
for about 53% of the GJB2-related HL cases, and represented 10.6% of the total Portuguese NSSHL 
patients. This predominance had also been observed in a different study conducted on a small 
number (n=53) of NSHL Portuguese patients (Nogueira et al, 2011), and in a sample of 100 
Portuguese cochlear implanted children, in which GJB2 genotype was shown to  correlate to better 
oral performance (Chora et al, 2011). 
 
Interestingly, the dominant GJB2 mutation p.M163L, causing mild/moderate high-frequency HL 
(Matos et al, 2008), has meanwhile also been found in one Argentinean patient presenting with 
prelingual, profound NSSHL (Dalamón et al, 2010), suggesting that the severity of the HL due to the 
p.M163L mutation might be variable and/or progressive. 
 
As regards the controversial but potentially pathogenic p.M34T (Feldmann et al, 2004; Snoeckx et al, 
2005; Bicego et al, 2006; Pollak et al, 2007) and p.R127H (RamShankar et al, 2003; Tóth et al, 2004; 
Bicego et al, 2006; Matos et al, 2010) variants, they were identified in patients harbouring an 
accompanying GJB2 variant or the del(GJB6-D13S1854) deletion. Those genotypes were here 
considered to be the likely cause of the HL, with some reservations regarding the only p.R127H 
homozygous patient (negative for the GJB6 deletions). Since other hearing impaired relatives of this 
patient were not available for study, we cannot know whether the p.R127H homozygous genotype is 
segregating with HL in the family. 
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The unclear p.V153I (RamShankar et al, 2003; Meşe et al, 2004; Snoeckx et al, 2005; Guerci et al, 
2007) and p.G160S (Janecke et al, 2002; Snoeckx et al, 2005) were identified in heterozygosity in two 
of our patients, respectively. No inference regarding the relation of their GJB2 genotype with the HL 
could be made. 
 
In which concerns genotype-phenotype correlation, truncating (T) mutations are usually associated 
with a greater degree of HL than nontruncating (NT) mutations (Cryns et al, 2004; Putcha et al, 2007; 
Snoeckx et al, 2005). However, variability in the degree of the hearing loss in T/T genotypes has been 
noticed, and is well exemplified by the significant intra- and inter-familial variation, ranging from mild 
to profound impairment, observed in c.35delG homozygotes (Cryns et al, 2004; Murgia et al, 1999). 
In the present study, the majority (n=17/23) of homozygotes for c.35delG with a reported phenotype 
had severe or profound HL, as expected. 
 
As opposed to T/T GJB2 genotypes, NT/NT GJB2 genotypes appear to be often associated with mild 
or moderate HL (Putcha et al, 2007; Snoeckx et al, 2005]. When considering NT/NT genotypes 
including at least one p.M34T or p.V37I allele, it was observed that they are usually, but not always, 
associated with less severe HL (Snoeckx et al, 2005). One patient of this study, with genotype 
p.[M34T] +[p.V95M], presented indeed with moderate HL. Two sporadic cases, compound 
heterozygous for p.V37I plus one of two other NT mutations, p.R184W and p.N206S, however 
presented with severe HL, thus supporting previous observations (Snoeckx et al, 2005). 
 
Regarding T/NT GJB2 genotypes, the variability on HL degree seems to depend on the NT mutation, 
at least when the T mutation is c.35delG (an early frameshift mutation). The two patients who were 
compound heterozygous for the p.V37I and c.35delG displayed mild and moderate HL, respectively, 
which is in accordance with the phenotypes previously found associated with this compound 
genotype by Cryns and co-workers (Cryns et al, 2004). The association of the [c.35delG]+[p.V37I] 
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genotype with less severe HL phenotypes was corroborated by other studies (Snoeckx et al, 2005; 
Pollak et al, 2007). One other T/NT GJB2 genotype, [c.35delG]+[p.L90P], is most commonly 
associated with mild or moderate HL (Cryns et al, 2004; Snoeckx et al, 2005; Pollak et al, 2007). Our 
patient presenting this genotype had a moderate hearing impairment. As regards the genotype 
[c.35delG]+[p.N206S], it apparently follows the same trend as the [c.35delG]+[p.L90P] genotype 
(Snoeckx et al, 2005; Marlin et al, 2005). The [c.35delG]+[p.N206S] patient here reported presented 
with moderate HL. Finally, the [c.35delG]+[p.V95M] genotype, here found in two patients with 
severe HL, effectively appears to be more often associated with severe to profound HL (Cryns et al, 
2004; Snoeckx et al, 2005) than with less severe HL (Cheng et al, 2005). 
 
In general, our data meet the view that the severity of GJB2-related HL can be correlated with 
specific mutation combinations (Cryns et al, 2004; Snoeckx et al, 2005). Variation in the phenotype 
for a given genotype would likely be dependent on more than one major modifier gene, as suggested 
by the study of Hilgert, Huentelman, and coworkers (Hilgert, Huentelman et al, 2009), as well as on 
environmental factors. 
 
In conclusion, GJB2 mutations are a major cause of NSSHL in the Portuguese population, c.35delG 
being  the predominant mutation, and each of the 19 other pathogenic/controversial variants 
occurring at much lower frequencies. Screening for the GJB2 donor splice site and basal promoter, 
and for the two common GJB6 deletions, allowed the elucidation of the HL etiology in some of the 
cases with only one coding mutation identified. Therefore, such screening, in patients harbouring 
only one coding mutation, is advisable and should be performed. 
Overall, more than one in five of the Portuguese patients have been diagnosed as having DFNB1-
related NSSHL. Analysis of GJB2 and GJB6 may thus represent a valuable indicator for clinicians, as 
regards therapeutical and rehabilitation options, as well as for genetic counselors of Portuguese 
patients and their families. 
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In fact, the current clinical assessment of hearing impaired children/patients includes regular and 
sometimes invasive clinical investigations due to the possibility of the occurrence of dysfunction in 
other organs (syndromic HL). A conclusive genetic diagnosis can avoid these follow-ups, leading to a 
significant reduction of clinical investigations and inherent costs.  Furthermore, the higher oral 
performance scores above referred, obtained in Portuguese cochlear implanted patients with 
DFNB1-associated deafness, show that individuals with this genetic etiology are good candidates for 
cochlear implantation, which represents an important prognostic tool. 
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Nucleotide change Amino acid change
c.-259C>T
a,b - Basal promoter Pathogenic    (T
c
) 1 (0.2)
c.-23+1G>A - Donor splice site Pathogenic   (T
c
) 2 (0.4)
c.-22-12C>T - Intron Polymorphism (NT
c
) 1 (0.2)
c.24G>A p.T8T N-terminus Novel           (NT) 1 (0.2)
c.35delG p.G12Vfs*2 N-terminus (frameshift) Pathogenic     (T) 84 (15.9)
c.71G>A
d p.W24X M1 (nonsense) Pathogenic     (T) 5 (0.9)
c.101T>C p.M34T M1 Controversial (NT) 7 (1.3)
c.109G>A p.V37I M1 Pathogenic    (NT) 5 (0.9)
c.139G>T p.E47X E1 (nonsense) Pathogenic     (T) 3 (0.6)
c.167delT p.L56Rfs*26 E1 (frameshift) Pathogenic   (T) 1 (0.2)
c.250G>A p.V84M M2 Pathogenic   (NT) 1 (0.2)
c.269T>C p.L90P M2 Pathogenic   (NT) 1 (0.2)
c.283G>A p.V95M M2 Pathogenic   (NT) 2 (0.4)
c.358_360delGAG p.E120del IC Pathogenic    (NT
e
) 3 (0.6)
c.380G>A p.R127H IC Controversial (NT) 6 (1.1)
c.457G>A p.V153I M3 Controversial (NT) 1 (0.2)
c.468G>A p.G160S E2 Unclear        (NT) 1 (0.2)
c.487A>C
a p.M163L E2 Pathogenic   (NT) 1 (0.2)
c.516G>A p.W172X E2 (nonsense) Pathogenic    (T) 3 (0.6)
c.550 C>G p.R184W E2 Pathogenic   (NT) 1 (0.2)
c.617A>G p.N206S M4 Pathogenic    (NT) 3 (0.6)
Abbreviations: E1-2 = extracellular domain 1 or 2; M1-4 = transmembrane domain 1, 2, 3 or 4; IC = 
intracellular domain (between M2 and M3); T = truncating mutation; NT = nontruncating mutation.
a. Mutations identified for the first time in the Portuguese population; b. Mutation up to now private of 
one Portuguese family; c. noncoding variant; d. Found in this study only in patients of Gypsy or Indian 
ethnicity/ancestry;   e. deletion of one nonterminal codon, thus considered to be a nontruncating 
mutation.
Alleles No. (Frequency)
Table 1 Frequency of GJB2  variant alleles (n= 528 chromosomes)
Variant
Location Effect
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Two variants
[c.35delG]+[c.-23+1G>A]
[c.35delG]+[p.W24X]
[c.35delG]+[p.M34T]
[c.35delG]+[c.167delT]
[c.35delG]+[p.L90P]
[c.35delG]+[p.V95M]
[c.35delG]+[p.E120del]
[c.35delG]+[p.N206S]
[p.W24X]+[p.W24X]
[p.W24X]+[p.R127H]
[p.M34T]+[p.V95M]
[p.V37I]+[p.R184W]
[p.V37I]+[p.N206S]
[p.V84M]+ [c.-259C>T]
[p.E120del]+[p.E120del]
[p.R127H]+[c.-23+1G>A]
[p.R127H]+[p.R127H]
Total
One variant
[=]+[p.R127H]
[=]+[c.-22-12C>T]
[=]+[p.T8T]
[=]+[p.W24X]
[=]+[p.V37I]
[=]+[p.V153I]
[=]+[G160S]
[p.M163L]+[=]
[=]+[p.N206S]
Total
Table 2 GJB2  genotypes of the 80 patients carrying GJB2  variants
1 Unreported
1 FC; 1 SC; 1 Un
2
GJB2  genotype Probands
(n=264)
HL
better ear
History
[=]+[c.35delG] 12 4.5
1
1 FC; 1 SC
1
Profound
5
Frequency %
Unreported
[c.35delG]+[c.35delG] 28 10.6
6 Moderate
9 FC; 9 SC; 10 Un
5 Severe
12
Profound
[c.35delG]+[p.V37I] 2 0.8
1 Mild
1 Moderate
1 FC; 2 Un1 Profound
1 Unreported
[c.35delG]+[p.W172X] 3 1.1
1 Moderate
[c.35delG]+[p.E47X] 3 1.1
1 Moderate
0.4 Profound Un
1 0.4 Moderate SC
1 0.4 Unreported Un
1 0.4 Severe FC
1 0.4 Moderate SC
1 0.4 Profound SC
1 0.4 Moderate SC
1 0.4 Moderate FC
1 0.4 Moderate FC
1 0.4 Moderate FC
1 0.4 Moderate FC
1 0.4 Severe SC
1 0.4 Severe SC
1 0.4 Profound FC
1 0.4 Moderate SC
1 0.4 Profound SC
1 0.4 Unreported FC
53 20.1
Mild
4 FC; 5 SC; 3 Un
3 Moderate
3 Severe
3 Profound
2 Unreported
[=]+[p.M34T] 5 1.9
1 Moderate
4 FC; 1 Un
1 Severe
2 Profound
2 0.8 2 Moderate 1 FC; 1 SC
1 0.4 Severe Un
1 0.4 Unreported FC
1 0.4 Severe FC
1 0.4 Profound SC
1 0.4 Mild FC
1 0.4 Moderate SC
1 0.4 Mild FC
Abbreviations: FC=Familiar Case; SC=Sporadic Case; Un=Unreported; Symbols: [=] - wild type allele.
1 0.4 Moderate Un
27 10.2
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